Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
1128
mi
from 02139
Inverness, FL
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1128
mi
from 02139
Inverness, FL
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
1108
mi
from 02139
Maitland, FL
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1108
mi
from 02139
Maitland, FL
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
1256
mi
from 02139
Miami, FL
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1256
mi
from 02139
Miami, FL
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
946
mi
from 02139
Macon, GA
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
946
mi
from 02139
Macon, GA
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
906
mi
from 02139
Suwanee, GA
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
906
mi
from 02139
Suwanee, GA
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
1304
mi
from 02139
Topeka, KA
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1304
mi
from 02139
Topeka, KA
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
1378
mi
from 02139
Baton Rouge, LA
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1378
mi
from 02139
Baton Rouge, LA
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
372
mi
from 02139
Columbia, MD
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
372
mi
from 02139
Columbia, MD
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
2
mi
from 02139
Boston, MA
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
643
mi
from 02139
Ann Arbor, MI
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
643
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
172
mi
from 02139
Manhasset, NY
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
172
mi
from 02139
Manhasset, NY
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
151
mi
from 02139
Poughkeepsie, NY
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
151
mi
from 02139
Poughkeepsie, NY
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
652
mi
from 02139
Winston-Salem, NC
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
652
mi
from 02139
Winston-Salem, NC
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
547
mi
from 02139
Cleveland, OH
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
547
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
1393
mi
from 02139
Tulsa, OK
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1393
mi
from 02139
Tulsa, OK
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
2530
mi
from 02139
Portland, OR
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2530
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
1123
mi
from 02139
Germantown, TN
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1123
mi
from 02139
Germantown, TN
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
3473
mi
from 02139
Bonheiden,
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
3473
mi
from 02139
Bonheiden,
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
1110
mi
from 02139
Winter Park, FL
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1110
mi
from 02139
Winter Park, FL
Click here to add this to my saved trials
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated:  12/31/1969
1033
mi
from 02139
Saint Louis, MO
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1033
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality of Life, Fatigue, Work Productivity, Liver Status and Cost-per-SVR/Health Care Utilization
Status: Enrolling
Updated:  12/31/1969
182
mi
from 02139
New York, NY
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality of Life, Fatigue, Work Productivity, Liver Status and Cost-per-SVR/Health Care Utilization
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine
182
mi
from 02139
New York, NY
Click here to add this to my saved trials
Prospective Study to Assess the Diagnostic Utility of Amyl Nitrite in Patients With Suspected Achalasia Undergoing High Resolution Esophageal Manometry (HREM)
Prospective Study to Assess the Diagnostic Utility of Amyl Nitrite in Patients With Suspected Achalasia Undergoing High Resolution Esophageal Manometry (HREM)
Status: Enrolling
Updated:  12/31/1969
356
mi
from 02139
Baltimore, MD
Prospective Study to Assess the Diagnostic Utility of Amyl Nitrite in Patients With Suspected Achalasia Undergoing High Resolution Esophageal Manometry (HREM)
Prospective Study to Assess the Diagnostic Utility of Amyl Nitrite in Patients With Suspected Achalasia Undergoing High Resolution Esophageal Manometry (HREM)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
356
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients
Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated:  12/31/1969
929
mi
from 02139
Madison, WI
Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients
Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
929
mi
from 02139
Madison, WI
Click here to add this to my saved trials
Sensorimotor Dysfunction in Achalasia
Sensorimotor Dysfunction in Achalasia
Status: Enrolling
Updated:  12/31/1969
1079
mi
from 02139
Rochester, MN
Sensorimotor Dysfunction in Achalasia
Sensorimotor Dysfunction in Achalasia
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers
A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects
Status: Enrolling
Updated:  12/31/1969
1772
mi
from 02139
Lakewood, CO
A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers
A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1772
mi
from 02139
Lakewood, CO
Click here to add this to my saved trials
A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers
A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects
Status: Enrolling
Updated:  12/31/1969
1118
mi
from 02139
Minneapolis, MN
A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers
A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1118
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers
A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects
Status: Enrolling
Updated:  12/31/1969
1115
mi
from 02139
Orlando, FL
A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers
A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1115
mi
from 02139
Orlando, FL
Click here to add this to my saved trials
Pilot Study to Image the Esophagus Using a SECM Tethered Endoscopic Capsule
Pilot Study for Imaging of Barrett's Esophagus Using an Spectrally Encoded Confocal Microscopy Tethered Endoscopic Capsule
Status: Enrolling
Updated:  12/31/1969
1
mi
from 02139
Boston, MA
Pilot Study to Image the Esophagus Using a SECM Tethered Endoscopic Capsule
Pilot Study for Imaging of Barrett's Esophagus Using an Spectrally Encoded Confocal Microscopy Tethered Endoscopic Capsule
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D
Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D
Status: Enrolling
Updated:  12/31/1969
2092
mi
from 02139
Murray, UT
Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D
Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D
Status: Enrolling
Updated: 12/31/1969
Intermountain Heart Institute
2092
mi
from 02139
Murray, UT
Click here to add this to my saved trials
Fecal Microbiota Transplant for Inflammatory Bowel Disease
Status: Enrolling
Updated:  12/31/1969
2692
mi
from 02139
San Francisco, CA
Fecal Microbiota Transplant for Inflammatory Bowel Disease
Status: Enrolling
Updated: 12/31/1969
UCSF Division of Gastroenterology at Mount Zion
2692
mi
from 02139
San Francisco, CA
Click here to add this to my saved trials
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated:  12/31/1969
1052
mi
from 02139
Birmingham, AL
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of Alabama Hospital
1052
mi
from 02139
Birmingham, AL
Click here to add this to my saved trials
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated:  12/31/1969
2586
mi
from 02139
Los Angeles, CA
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of Southern California
2586
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated:  12/31/1969
821
mi
from 02139
Louisville, KY
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of Louisville
821
mi
from 02139
Louisville, KY
Click here to add this to my saved trials
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated:  12/31/1969
357
mi
from 02139
Baltimore, MD
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of Maryland Medical Center
357
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated:  12/31/1969
2530
mi
from 02139
Portland, OR
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
2530
mi
from 02139
Portland, OR
Click here to add this to my saved trials
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated:  12/31/1969
1605
mi
from 02139
Houston, TX
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
1605
mi
from 02139
Houston, TX
Click here to add this to my saved trials
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated:  12/31/1969
2586
mi
from 02139
Fresno, CA
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated: 12/31/1969
Limb Preservation Platform
2586
mi
from 02139
Fresno, CA
Click here to add this to my saved trials
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated:  12/31/1969
811
mi
from 02139
Indianapolis, IN
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated: 12/31/1969
The Miller Care Group
811
mi
from 02139
Indianapolis, IN
Click here to add this to my saved trials
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated:  12/31/1969
240
mi
from 02139
Dunmore, PA
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated: 12/31/1969
Wound Institute & Research Center
240
mi
from 02139
Dunmore, PA
Click here to add this to my saved trials
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated:  12/31/1969
268
mi
from 02139
Philadelphia, PA
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated: 12/31/1969
Temple University School of Pediatric Medicine
268
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated:  12/31/1969
1551
mi
from 02139
Dallas, TX
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated: 12/31/1969
Richard C. Galperin, DPM, FAPWCA
1551
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated:  12/31/1969
1417
mi
from 02139
Opelousas, LA
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated: 12/31/1969
The Wound Treatment Center
1417
mi
from 02139
Opelousas, LA
Click here to add this to my saved trials
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated:  12/31/1969
1895
mi
from 02139
McAllen, TX
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)
Status: Enrolling
Updated: 12/31/1969
Futuro Clinical Trials, LLC
1895
mi
from 02139
McAllen, TX
Click here to add this to my saved trials
Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients
Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated:  12/31/1969
929
mi
from 02139
Madison, WI
Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients
Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
929
mi
from 02139
Madison, WI
Click here to add this to my saved trials
A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Status: Enrolling
Updated:  12/31/1969
1116
mi
from 02139
Minneapolis, MN
A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Medical Center
1116
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
Crohn Disease Exclusion Diet After Single Medication De-escalation
Biologic and Immunomodulator Withdrawal in Pediatric Crohn Disease With Deep Clinical Remission Using the Crohn Disease Exclusion Diet
Status: Enrolling
Updated:  12/31/1969
268
mi
from 02139
Philadelphia, PA
Crohn Disease Exclusion Diet After Single Medication De-escalation
Biologic and Immunomodulator Withdrawal in Pediatric Crohn Disease With Deep Clinical Remission Using the Crohn Disease Exclusion Diet
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
268
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Phase I Study to Determine the Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Status: Enrolling
Updated:  12/31/1969
929
mi
from 02139
Decatur, GA
Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Phase I Study to Determine the Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Status: Enrolling
Updated: 12/31/1969
Emory Vaccine Center - The Hope Clinic
929
mi
from 02139
Decatur, GA
Click here to add this to my saved trials
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
A Long-Term Open-Label Extension Study of RP103-MITO-001 to Assess the Safety, Tolerability and Efficacy of Cysteamine Bitartrate Delayed-release Capsules (RP103) for Treatment of Children With Inherited Mitochondrial Disease
Status: Enrolling
Updated:  12/31/1969
543
mi
from 02139
Akron, OH
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
A Long-Term Open-Label Extension Study of RP103-MITO-001 to Assess the Safety, Tolerability and Efficacy of Cysteamine Bitartrate Delayed-release Capsules (RP103) for Treatment of Children With Inherited Mitochondrial Disease
Status: Enrolling
Updated: 12/31/1969
Akron Children's Hospital
543
mi
from 02139
Akron, OH
Click here to add this to my saved trials
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
A Long-Term Open-Label Extension Study of RP103-MITO-001 to Assess the Safety, Tolerability and Efficacy of Cysteamine Bitartrate Delayed-release Capsules (RP103) for Treatment of Children With Inherited Mitochondrial Disease
Status: Enrolling
Updated:  12/31/1969
1601
mi
from 02139
Houston, TX
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
A Long-Term Open-Label Extension Study of RP103-MITO-001 to Assess the Safety, Tolerability and Efficacy of Cysteamine Bitartrate Delayed-release Capsules (RP103) for Treatment of Children With Inherited Mitochondrial Disease
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
A Long-Term Open-Label Extension Study of RP103-MITO-001 to Assess the Safety, Tolerability and Efficacy of Cysteamine Bitartrate Delayed-release Capsules (RP103) for Treatment of Children With Inherited Mitochondrial Disease
Status: Enrolling
Updated:  12/31/1969
2575
mi
from 02139
San Diego, CA
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
A Long-Term Open-Label Extension Study of RP103-MITO-001 to Assess the Safety, Tolerability and Efficacy of Cysteamine Bitartrate Delayed-release Capsules (RP103) for Treatment of Children With Inherited Mitochondrial Disease
Status: Enrolling
Updated: 12/31/1969
University of California - San Diego (UCSD)
2575
mi
from 02139
San Diego, CA
Click here to add this to my saved trials